-
January 31, 2022 Why Mindset Pharma’s Deal with Big Pharma Is a Big Deal for PsychedelicsThe partnership with global pharmaceutical company Otsuka positions the psychedelic medicine company as a leader...
-
January 28, 2022 Psychedelic Business Spotlight — January 28This week in psychedelic business news: A major player begins manufacturing; another rebrands; and one...
-
January 27, 2022 Colorado Lawmakers and Activists Push for Wide-Ranging Psychedelic ReformTrio of lawmakers propose a psychedelic reform review panel, while two ballot initiatives push legalization...
-
January 26, 2022 Oklahoma GOP Lawmakers Push for Psychedelic ReformBiggest difference between the two proposed bills: one decriminalizes plant medicine.
-
January 24, 2022 How to Prepare for Your First Psychedelic Trip in 5 Easy StepsPsilocybin and LSD are becoming more popular and more accessible, but before your first psychedelic...
-
January 21, 2022 Psychedelic Business Spotlight – January 21Catch up on some of the biggest psychedelic business developments that unfolded in the last...
-
January 19, 2022 Majority of Mental Health Patients Support Access to Psychedelics, Survey FindsAmericans continue to open their minds to ketamine, psilocybin, and MDMA treatment for depression, anxiety,...
-
January 18, 2022 Psychedelics ‘Train Has Left the Station’ Says Federal Drug Official as More States Seek AccessA Republican in Missouri and two Democrats in Virginia file bills that push the psychedelics...
-
January 11, 2022 Promising Psychedelic Therapy Legislation Set to Make Waves in 2022California's not alone. Florida, Michigan, New York, and more U.S. states may pass psychedelic therapy...
-
January 4, 2022 Health Canada Grants Special Access to Restricted Drugs for Psychedelic TherapyNew amendment reverses a 2013 Health Canada policy that prevented "a letter of authorization for...
